Judge Rules For Andrx In Bristol-Myers Patent Suit Over Monopril

Law360, New York (June 7, 2004, 12:00 AM EDT) -- Andrx Corp. does not infringe a patent that Bristol-Myers Squibb Co. holds for its Monopril hypertension drug, a federal judge has ruled in a decision that clears the way for Andrx to sell generic version of the product.

Bristol-Myers' lawsuit was not "based on scientifically sound principles" or justifiable patent claims, U.S. District Judge Paul Huck wrote in a 52-page order after hearing the trial without a jury last month.

Bristol-Myers filed suit against the Florida-based defendants in New York and Florida in 2003, after learning...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.